Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
Cartilage healing has been an intractable problem for millennia. Today, osteoarthritis, caused by cartilage damage, afflicts over 30 million people in the United States alone. Each patient will spend over $200,000 to treat this condition over his or her lifetime. Ultimately, current therapies fail to heal cartilage damage. Patients wait an average of 13 years to receive an end-stage treatment: an invasive and traumatic total joint replacement.
We are a company that brings together basic science, preclinical, regulatory, and manufacturing expertise to further the commercialization of cartilage regeneration products to eliminate the need for further treatments and improve patient quality of life.